Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;93(4):697-700.
doi: 10.4269/ajtmh.15-0092. Epub 2015 Jul 20.

Detection of Chikungunya Virus in Nepal

Basu Dev Pandey  1 , Biswas Neupane  2 , Kishor Pandey  2 , Mya Myat Ngwe Tun  2 , Kouichi Morita  2
Affiliations

Detection of Chikungunya Virus in Nepal

Basu Dev Pandey et al. Am J Trop Med Hyg. 2015 Oct.

Abstract

Chikungunya virus (CHIKV) is an emerging alphaviral disease and a public health problem in South Asia including Nepal in recent years. In this study, sera were collected from patients presenting with fever, headache, muscular pain, fatigue, and joint pain of both upper and lower extremities. A total of 169 serum samples were tested for CHIKV and dengue virus (DENV) by using Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibody using enzyme-linked immunosorbent assay (ELISA) method during August to November 2013. Results showed that 3.6% and 27.8% samples were positive for CHIKV and DENV IgM positive, respectively. Similarly, results of IgG showed 3.0% samples were positive for CHIKV IgG and 29.0% were for DENV IgG positive. Further, a 50% focal reduction neutralization test (FRNT50) was performed to confirm the presence of CHIKV, which demonstrated that 8.9% of CHIKV IgM and/or IgG ELISA positive possessed neutralizing anti-CHIK antibodies. To our knowledge, this is the first report in which the presence of CHIKV is confirmed in Nepalese patients by FRNT50. Basic scientists and clinicians need to consider CHIKV as a differential diagnosis in febrile Nepalese patients, and policy makers should consider appropriate surveillance and actions for control strategies.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Map of Nepal showing three ecological zones, five development regions, 75 districts, and study sites.
See this image and copyright information in PMC

References

    1. Hochedez P, Jaureguiberry S, Debruyne M, Bossi P, Hausfater P, Brucker G, Bricaire F, Caumes E. Chikungunya infection in travellers. Emerg Infect Dis. 2006;12:1565–1567. - PMC - PubMed
    1. Lumsden WHR. An epidemic of virus disease in southern province, Tanganyika territory, in 1952–53: II. General description and epidemiology. Trans R Soc Trop Med Hyg. 1995;49:33–57. - PubMed
    1. Economopoulou A, Dominguez M, Helynck B, Sissoko D, Wichmann O, Quenel P, Germonneau P, Quatresous I. A typical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Reunion. Epidemiol Infect. 2009;137:534–541. - PubMed
    1. PAHO Number of Reported Cases of Chikungunya Fever in the Americas—EW 13. 2015. http://www.paho.org/hq/ Available at. Accessed April 4, 2015.
    1. Carey DE. Chikungunya and dengue: a case of mistaken identity? J Hist Med Allied Sci. 1971;26:243–262. - PubMed